These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2936657)

  • 1. [Effect of medroxyprogesterone (MPA) on blood levels of FSH, LH and prolactin in women].
    Kotarski J; Jakowicki J
    Ginekol Pol; 1985 Oct; 56(10):581-4. PubMed ID: 2936657
    [No Abstract]   [Full Text] [Related]  

  • 2. Induced prolactin release in women under long-term medroxyprogesterone acetate treatment.
    Perez-Lopez FR; Roncero MC
    Obstet Gynecol; 1975 Mar; 45(3):263-6. PubMed ID: 803668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebo-controlled comparison of hormonal and biochemical effects of danazol and high-dose medroxyprogesterone acetate.
    Telimaa S; Apter D; Reinilä M; Rönnberg L; Kauppila A
    Eur J Obstet Gynecol Reprod Biol; 1990; 36(1-2):97-105. PubMed ID: 2142109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal effects of high dose medroxyprogesterone acetate treatment in males with renal or prostatic adenocarcinoma.
    Tomić R; Ljungberg B; Damber JE
    Scand J Urol Nephrol; 1988; 22(1):15-8. PubMed ID: 2968646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of medroxyprogesterone acetate in women with polycystic ovary syndrome.
    Petsos P; Ratcliffe WA; Anderson DC
    Clin Endocrinol (Oxf); 1986 Dec; 25(6):651-60. PubMed ID: 2958179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for the hypothalamic origin of the polycystic ovary syndrome.
    Wortsman J; Singh KB; Murphy J
    Obstet Gynecol; 1981 Aug; 58(2):137-41. PubMed ID: 6454866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenohypophyseal function in bitches treated with medroxyprogesterone acetate.
    Beijerink NJ; Bhatti SF; Okkens AC; Dieleman SJ; Mol JA; Duchateau L; Van Ham LM; Kooistra HS
    Domest Anim Endocrinol; 2007 Feb; 32(2):63-78. PubMed ID: 16455223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate.
    Cedars MI; Lu JK; Meldrum DR; Judd HL
    Obstet Gynecol; 1990 Apr; 75(4):641-5. PubMed ID: 2138265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulsatile plasma profiles of FSH and LH before and during medroxyprogesterone acetate treatment in the bitch.
    Beijerink NJ; Bhatti SF; Okkens AC; Dieleman SJ; Duchateau L; Kooistra HS
    Theriogenology; 2008 Jul; 70(2):179-85. PubMed ID: 18455225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of correlations between plasma concentration of medroxyprogesterone acetate, hypothalamic-pituitary function, and tumour response in patients with advanced breast cancer.
    Hedley DW; Christie M; Weatherby RP; Caterson ID
    Cancer Chemother Pharmacol; 1985; 14(2):112-5. PubMed ID: 3156002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin, steroid, and inhibin levels in women with incipient ovarian failure during anovulatory and ovulatory rebound cycles.
    Buckler HM; Evans CA; Mamtora H; Burger HG; Anderson DC
    J Clin Endocrinol Metab; 1991 Jan; 72(1):116-24. PubMed ID: 1824706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blood serum content of prolactin, follicle-stimulating hormone, luteinizing hormone, estradiol and progesterone in women with normal menstrual cycle].
    Khamad'ianov UR; Laricheva IP; Smirnova LK
    Probl Endokrinol (Mosk); 1980; 26(2):32-7. PubMed ID: 6769108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of high-dose medroxyprogesterone acetate on plasma hormone levels and pain relief in patients with advanced prostatic cancer.
    Sasagawa I; Satomi S
    Br J Urol; 1990 Mar; 65(3):278-81. PubMed ID: 1692498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadotrophins and prolactin rise after bilateral oophorectomy for benign conditions.
    Crosignani PG; Meschia M; Bruschi F; Amicarelli F; Parazzini F
    Hum Reprod; 1995 Sep; 10(9):2277-9. PubMed ID: 8530651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of medroxyprogesterone acetate on serum levels of LH, FSH, cortisol, and estrone in patients with endometrial carcinoma.
    Vesterinen E; Backas NE; Pesonen K; Stenman UH; Laatikainen T
    Arch Gynecol; 1981; 230(3):205-11. PubMed ID: 6787991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The assessment of the basal levels of serum luteinizing hormone (LH), follicle stimulating hormone (FSH) and prolactin (PRL) in the Thai subjects.
    Namking M; Himathongkam T; Pavasuthipaisit K; Supasri Y; Pitchayayothin N; Rimdusit P
    J Med Assoc Thai; 1980 May; 63(5):267-75. PubMed ID: 6771351
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis.
    Luciano AA; Turksoy RN; Carleo J
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):323-7. PubMed ID: 2970029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the correlation between FSH, LH and prolactin serum levels.
    Krause W
    Endokrinologie; 1978 May; 72(2):129-35. PubMed ID: 104865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Physiopathology of amenorrhea caused by medroxyprogesterone acetate].
    Rivera Damm R; Ruiz MR; Pérez Palacios G; Gaitán JR; Alonso MR
    Ginecol Obstet Mex; 1977 Dec; 42(254):359-67. PubMed ID: 162599
    [No Abstract]   [Full Text] [Related]  

  • 20. Recurrent endometriosis following hysterectomy and oophorectomy: the role of residual ovarian fragments.
    Dmowski WP; Radwanska E; Rana N
    Int J Gynaecol Obstet; 1988 Feb; 26(1):93-103. PubMed ID: 2892745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.